Mexico Mice Model Market (2025-2030)
The Mexico Mice Model Market was valued at $5.26 Million in 2025 and projected to reach to $6.85 Million by 2030, representing a compound annual growth rate of CAGR 5.4%. Mexico's mice model market is positioned for steady growth as pharmaceutical and biotechnology companies expand their preclinical research operations in the country.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Mexico Mice Model Market Trends and Insights
- Mexico's market reflects steady demand from academic research institutions, pharmaceutical companies, and contract research organizations conducting preclinical studies.
- The growth trajectory in Mexico is supported by increasing investment in life sciences research and the country's expanding role in regional drug development and biomedical innovation. The mice model market in Mexico is driven by the rising adoption of in vivo research models for disease modeling, drug efficacy testing, and safety assessment.
- Mexico's research infrastructure continues to modernize, with universities and private research facilities increasingly utilizing genetically modified and specialized mouse strains.
- Between 2025 and 2030, Mexico is expected to see enhanced regulatory support for preclinical research, further bolstering demand for high-quality laboratory mice and associated breeding services. Mexico's position within Latin America's broader life sciences ecosystem positions the country as an emerging hub for preclinical research outsourcing.
- The market in Mexico benefits from cost advantages relative to North American alternatives while maintaining quality standards, attracting multinational pharmaceutical and biotechnology firms to establish or expand research operations in the region..
Key Market Statistics
- CAGR (2025-2030) CAGR 5.4%
- Market Size, 2025 ~USD 5.26 Million
- Forecast, 2030 ~USD 6.85 Million
- Country Mexico
Mexico Mice Model Market Overview
Market Valuation :
Mexico's mice model market is valued at $5.26 million in 2025, with projected growth to $6.85 million by 2030, demonstrating steady expansion in the preclinical research sector.
Growth Rate :
The Mexican market exhibits a CAGR of 5.4% from 2025 to 2030, reflecting moderate but consistent growth driven by increased research activities and pharmaceutical development initiatives.
Key Market Drivers :
Mexico's mice model market is supported by growing demand from academic research institutions, pharmaceutical companies, and contract research organizations conducting preclinical studies and drug development.
Research Infrastructure :
Increasing investments in research facilities and collaborations with international pharmaceutical firms are strengthening Mexico's position as a preclinical research hub in Latin America.
Mexico Mice Model Market Dynamics
- The market benefits from Mexico's strategic location, cost-effective research capabilities, and growing academic research infrastructure.
- Increased collaboration between Mexican research institutions and international pharmaceutical firms is expected to drive demand for laboratory mice and related research services. Looking ahead to 2030, Mexico's market will likely experience sustained growth fueled by rising investments in drug discovery, regulatory compliance requirements, and the expansion of contract research organizations.
- The country's role in the broader Latin American research ecosystem, combined with improving laboratory standards and research capabilities, positions Mexico as an increasingly attractive destination for preclinical studies and mice model research..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Mexico's mice model market is valued at $5.26 million in 2025 and will reach $6.85 million by 2030 at a 5.4% CAGR.
- Mexico's market growth is driven by increased pharmaceutical R&D investment and modernization of academic research infrastructure.
- Mexico serves as a cost-competitive preclinical research hub within Latin America, attracting multinational pharmaceutical outsourcing.
- Specialized and genetically modified mouse strains are gaining adoption in Mexico's research institutions for advanced disease modeling.
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area, End User |
Mexico Mice Model Market Report Segmentation
6 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
By End User
- Academic & Research Institutes
- Contract Research Organizations (Cros) & Contract Development And Manufacturing Organizations (Cdmos)
- Pharmaceutical & Biotechnology Companies
MEXICO: MICE MODEL TYPE MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 1.7 | 1.8 | 1.9 | 2 | 2.1 | 2.2 | 2.3 | 2.4 | 4.7 |
| CROS & CDMOS | 0.8 | 0.9 | 0.9 | 1 | 1 | 1.1 | 1.1 | 1.2 | 5.3 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 2.1 | 2.3 | 2.5 | 2.6 | 2.8 | 3 | 3.1 | 3.3 | 5.9 |
| TOTAL | 4.7 | 4.9 | 5.3 | 5.6 | 6 | 6.3 | 6.6 | 6.8 | 5.4 |
Target Audience
- Pharmaceutical Companies : Pharmaceutical firms conducting preclinical research in Mexico need market data to optimize their research operations, identify local suppliers, and plan expansion of drug development activities.
- Contract Research Organizations : CROs operating in Mexico require detailed market insights to understand demand trends, competitive positioning, and growth opportunities in the preclinical research outsourcing sector.
- Laboratory Animal Suppliers : Suppliers of laboratory mice and related products need Mexico-specific market intelligence to identify customer segments, assess market potential, and develop distribution strategies.
- Academic Research Institutions : Mexican universities and research centers use market data to benchmark their research capabilities, identify collaboration opportunities, and secure funding for preclinical studies.
- Investment & Business Development : Investors and business development professionals evaluating opportunities in Mexico's life sciences sector need comprehensive market analysis to assess growth potential and identify strategic partnerships.
Key Companies in the Mexico Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Reasons to Buy this Report
- Market Entry Strategy : Gain comprehensive insights into Mexico's mice model market dynamics to develop targeted market entry strategies and identify key growth opportunities in this emerging preclinical research hub.
- Competitive Positioning : Understand Mexico-specific market trends, key players, and competitive landscape to effectively position your products and services against local and international competitors.
- Investment Decision Support : Access detailed market forecasts and growth projections through 2030 to make informed investment decisions regarding research facility expansion or partnership development in Mexico.
- Customer Identification : Identify and profile key customer segments including academic institutions, pharmaceutical companies, and CROs operating in Mexico to optimize sales and marketing efforts.
- Regulatory & Operational Insights : Understand Mexico-specific regulatory requirements, research standards, and operational considerations essential for successfully launching or scaling mice model products and services.
Frequently asked questions
What is the current size of Mexico's mice model market?
Mexico's mice model market is valued at $5.26 million in 2025 and is expected to grow to $6.85 million by 2030.
What is the projected growth rate for Mexico's mice model market?
Mexico's mice model market is projected to grow at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2030.
What are the primary drivers of growth in Mexico's mice model market?
Growth in Mexico's market is driven by increased pharmaceutical R&D investment, modernization of research infrastructure, and Mexico's emergence as a cost-competitive preclinical research outsourcing destination.
Which sectors are the largest consumers of mice models in Mexico?
Academic research institutions, pharmaceutical companies, biotechnology firms, and contract research organizations are the primary consumers of mice models in Mexico.
How does Mexico's mice model market compare to other Latin American countries?
Mexico represents a significant portion of Latin America's mice model market, benefiting from established research infrastructure, regulatory frameworks, and proximity to North American pharmaceutical markets.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- Germany Mice Model Market
- UK Mice Model Market
- France Mice Model Market
- Italy Mice Model Market
- Spain Mice Model Market
- China Mice Model Market
- Japan Mice Model Market
- India Mice Model Market
- Australia Mice Model Market
- South Korea Mice Model Market
- Brazil Mice Model Market
- United Arab Emirates Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
- Rest Of Latin America Mice Model Market
- Ksa Mice Model Market
- Other GCC Countries Mice Model Market
- UAE Mice Model Market
- GCC Countries Mice Model Market
- Rest Of The Middle East Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report